Maplebear Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Maplebear Inc. reported revenue of $3.7B (+10.8% year on year) and net income of $447.0M (-2.2% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY |
|---|---|---|---|
| Revenue | $3.7B | $3.4B | $3.0B |
| Cost of revenue | $984.0M | $836.0M | $764.0M |
| Gross profit | $2.8B | $2.5B | $2.3B |
| Operations and support | $274.0M | $278.0M | $344.0M |
| Research and development | $650.0M | $604.0M | $2.3B |
| Sales and marketing | $854.0M | $808.0M | $961.0M |
| General and administrative | $482.0M | $363.0M | $803.0M |
| Total operating expenses | $2.3B | $2.1B | $4.4B |
| Income (loss) from operations | $498.0M | $489.0M | ($2.1B) |
| Other income (expense), net | $1.0M | ($3.0M) | $0 |
| Interest income | $57.0M | $66.0M | $81.0M |
| Income (loss) before provision for (benefit from) income taxes | $556.0M | $552.0M | ($2.1B) |
| Provision for (benefit from) income taxes | $109.0M | $95.0M | ($439.0M) |
| Net income (loss) | $447.0M | $457.0M | ($1.6B) |
| Accretion related to Series A redeemable convertible preferred stock | ($9.0M) | ($9.0M) | ($2.0M) |
| Net income (loss) attributable to common stockholders, basic | $438.0M | $448.0M | ($1.6B) |
| Accretion related to Series A redeemable convertible preferred stock | $9.0M | $9.0M | — |
| Net income (loss) attributable to common stockholders, diluted | $447.0M | $457.0M | ($1.6B) |
| Basic (in dollars per share) | $1.68 | $1.69 | -$12.43 |
| Diluted (in dollars per share) | $1.60 | $1.58 | -$12.43 |
| Basic (in shares) | 261.4M | 264.6M | 130.6M |
| Diluted (in shares) | 279.6M | 289.2M | 130.6M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $939.0M | $914.0M |
| Cost of revenue | $292.0M | $281.0M | $247.0M | $236.0M |
| Gross profit | $751.0M | $738.0M | $692.0M | $678.0M |
| Operations and support | $74.0M | $74.0M | $62.0M | $66.0M |
| Research and development | $202.0M | $164.0M | $169.0M | $166.0M |
| Sales and marketing | $233.0M | $230.0M | $206.0M | $217.0M |
| General and administrative | $98.0M | $88.0M | $87.0M | $106.0M |
| Total operating expenses | $608.0M | $556.0M | $525.0M | $554.0M |
| Income from operations | $143.0M | $182.0M | $166.0M | $124.0M |
| Other income (expense), net | ($1.0M) | — | ($1.0M) | $3.0M |
| Interest income | $5.0M | $6.0M | $16.0M | $15.0M |
| Income before provision for income taxes | $147.0M | $188.0M | $181.0M | $142.0M |
| Provision for income taxes | $36.0M | $44.0M | $37.0M | $26.0M |
| Net income | $111.0M | $144.0M | $144.0M | $116.0M |
| Accretion related to Series A redeemable convertible preferred stock | ($2.0M) | ($2.0M) | ($2.0M) | ($2.0M) |
| Net income attributable to common stockholders, basic | $109.0M | $142.0M | $142.0M | $114.0M |
| Accretion related to Series A redeemable convertible preferred stock | $2.0M | $2.0M | $2.0M | $2.0M |
| Net income attributable to common stockholders, diluted | $111.0M | $144.0M | $144.0M | $116.0M |
| Basic (in dollars per share) | $0.46 | $0.59 | $0.54 | $0.43 |
| Diluted (in dollars per share) | $0.45 | $0.57 | $0.51 | $0.41 |
| Basic (in shares) | 234.9M | 239.3M | 264.9M | 262.6M |
| Diluted (in shares) | 248.9M | 253.6M | 283.2M | 281.3M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY |
|---|---|---|---|
| Cash and cash equivalents | $637.0M | $1.3B | $2.1B |
| Short-term marketable securities | $50.0M | $91.0M | $49.0M |
| Accounts receivable, net of allowance of $4 and $3, respectively | $1.1B | $1.0B | $853.0M |
| Restricted cash and cash equivalents, current | $172.0M | $152.0M | $137.0M |
| Prepaid expenses and other current assets | $213.0M | $162.0M | $129.0M |
| Total current assets | $2.2B | $2.7B | $3.3B |
| Long-term marketable securities | $81.0M | — | $0 |
| Restricted cash and cash equivalents, noncurrent | $18.0M | $19.0M | $19.0M |
| Property and equipment, net | $218.0M | $200.0M | $135.0M |
| Operating lease right-of-use assets | $30.0M | $21.0M | $31.0M |
| Intangible assets, net | $71.0M | $52.0M | $77.0M |
| Goodwill | $393.0M | $317.0M | $318.0M |
| Deferred tax assets, net | $664.0M | $771.0M | $830.0M |
| Other assets | $14.0M | $38.0M | $12.0M |
| Total assets | $3.7B | $4.1B | $4.7B |
| Accounts payable | $70.0M | $80.0M | $72.0M |
| Accrued and other current liabilities | $634.0M | $505.0M | $451.0M |
| Operating lease liabilities, current | $3.0M | $13.0M | $13.0M |
| Deferred revenue | $211.0M | $200.0M | $197.0M |
| Total current liabilities | $917.0M | $798.0M | $733.0M |
| Operating lease liabilities, noncurrent | $33.0M | $13.0M | $27.0M |
| Other long-term liabilities | $24.0M | $25.0M | $40.0M |
| Total liabilities | $974.0M | $836.0M | $800.0M |
| Series A redeemable convertible preferred stock; $0.0001 par value per share; 5,833 shares authorized, issued, and outstanding as of December 31, 2024 and 2025 | $196000000.00 | $186000000.00 | $177000000.00 |
| Preferred stock, $0.0001 par value per share; 24,167 shares authorized as of December 31, 2024 and 2025; zero shares issued and outstanding as of December 31, 2024 and 2025 | $0.00 | $0.00 | $0.00 |
| Common stock, $0.0001 par value per share; $2,000,000 shares authorized as of December 31, 2024 and 2025; 260,964 and $242,867 shares issued and outstanding as of December 31, 2024 and 2025, respectively | $0.00 | $0.00 | $0.00 |
| Additional paid-in capital | $7.0B | $6.7B | $6.4B |
| Accumulated other comprehensive loss | ($1.0M) | ($9.0M) | $3.0M |
| Accumulated deficit | ($4.5B) | ($3.6B) | ($2.6B) |
| Total stockholders’ equity | $2.5B | $3.1B | $3.8B |
| Total liabilities, redeemable convertible preferred stock, and stockholders’ equity | $3.7B | $4.1B | $4.7B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $757.0M | $631.0M | $1.7B | $1.5B |
| Short-term marketable securities | $93.0M | $59.0M | $39.0M | $109.0M |
| Accounts receivable, net of allowance of $3 and $2, respectively | $979.0M | $1.1B | $1.0B | $1.0B |
| Restricted cash and cash equivalents, current | $117.0M | $110.0M | $126.0M | $122.0M |
| Prepaid expenses and other current assets | $171.0M | $197.0M | $134.0M | $127.0M |
| Total current assets | $2.1B | $2.1B | $3.0B | $2.9B |
| Long-term marketable securities | $35.0M | $63.0M | $62.0M | — |
| Restricted cash and cash equivalents, noncurrent | $0 | $18.0M | $18.0M | $15.0M |
| Property and equipment, net | $218.0M | $219.0M | $218.0M | $221.0M |
| Operating lease right-of-use assets | $27.0M | $28.0M | $31.0M | $33.0M |
| Intangible assets, net | $66.0M | $60.0M | $74.0M | $81.0M |
| Goodwill | $412.0M | $393.0M | $392.0M | $392.0M |
| Deferred tax assets, net | $596.0M | $626.0M | $696.0M | $775.0M |
| Other assets | $39.0M | $37.0M | $18.0M | $25.0M |
| Total assets | $3.5B | $3.5B | $4.5B | $4.4B |
| Accounts payable | $62.0M | $48.0M | $78.0M | $69.0M |
| Accrued and other current liabilities | $631.0M | $604.0M | $532.0M | $579.0M |
| Operating lease liabilities, current | $3.0M | $2.0M | $3.0M | $3.0M |
| Deferred revenue | $232.0M | $230.0M | $219.0M | $220.0M |
| Total current liabilities | $929.0M | $885.0M | $832.0M | $871.0M |
| Operating lease liabilities, noncurrent | $31.0M | $32.0M | $34.0M | $34.0M |
| Other long-term liabilities | $27.0M | $24.0M | $23.0M | $37.0M |
| Total liabilities | $988.0M | $941.0M | $889.0M | $942.0M |
| Series A redeemable convertible preferred stock; $0.0001 par value per share; 5,833 shares authorized, issued, and outstanding as of December 31, 2025 and June 30, 2026 | $200000000.00 | $198000000.00 | $193000000.00 | $191000000.00 |
| Preferred stock, $0.0001 par value per share; 24,167 shares authorized as of December 31, 2025 and June 30, 2026; zero shares issued and outstanding as of December 31, 2025 and June 30, 2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock, $0.0001 par value per share; $2,000,000 shares authorized as of December 31, 2025 and June 30, 2026; 242,867 and $233,035 shares issued and outstanding as of December 31, 2025 and June 30, 2026, respectively | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional paid-in capital | $7.3B | $7.1B | $7.0B | $6.9B |
| Accumulated other comprehensive loss | ($7.0M) | ($4.0M) | ($4.0M) | ($1.0M) |
| Accumulated deficit | ($5.0B) | ($4.7B) | ($3.5B) | ($3.6B) |
| Total stockholders’ equity | $2.3B | $2.4B | $3.5B | $3.3B |
| Total liabilities, redeemable convertible preferred stock, and stockholders’ equity | $3.5B | $3.5B | $4.5B | $4.4B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY |
|---|---|---|---|
| Net income (loss) | $447.0M | $457.0M | ($1.6B) |
| Depreciation and amortization expense | $91.0M | $56.0M | $43.0M |
| Stock-based compensation expense | $352.0M | $300.0M | $2.8B |
| Impairments of long-lived assets and other assets | $24.0M | — | — |
| Provision for bad debts | $15.0M | $19.0M | $23.0M |
| Amortization of operating lease right-of-use assets | $8.0M | $11.0M | $14.0M |
| Deferred income taxes | $98.0M | $59.0M | ($459.0M) |
| Other | ($2.0M) | $4.0M | ($4.0M) |
| Accounts receivable | ($121.0M) | ($185.0M) | ($33.0M) |
| Prepaid expenses and other assets | ($30.0M) | ($58.0M) | ($22.0M) |
| Accounts payable | ($11.0M) | $8.0M | ($16.0M) |
| Accrued and other current liabilities | $100.0M | $42.0M | ($62.0M) |
| Deferred revenue | $10.0M | $4.0M | $18.0M |
| Operating lease liabilities | ($7.0M) | ($16.0M) | ($15.0M) |
| Other long-term liabilities | ($2.0M) | ($14.0M) | ($35.0M) |
| Net cash provided by operating activities | $971.0M | $687.0M | $586.0M |
| Purchases of marketable securities | ($280.0M) | ($110.0M) | ($110.0M) |
| Maturities of marketable securities | $243.0M | $70.0M | $301.0M |
| Purchases of property and equipment, including capitalized internal-use software | ($61.0M) | ($64.0M) | ($54.0M) |
| Acquisitions of businesses, net of cash acquired | ($106.0M) | $0 | $0 |
| Other investing activities | ($5.0M) | ($3.0M) | — |
| Net cash provided by (used in) investing activities | ($208.0M) | ($107.0M) | $135.0M |
| Proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts | $0 | $0 | $401.0M |
| Proceeds from the issuance of Series A redeemable convertible preferred stock | $0 | $0 | $175.0M |
| Taxes paid related to net share settlement of equity awards | ($24.0M) | ($101.0M) | ($570.0M) |
| Proceeds from exercise of stock options | $8.0M | $80.0M | $6.0M |
| Changes in advances from payment card issuer | $12.0M | $10.0M | — |
| Deferred offering costs paid | $0 | $0 | ($6.0M) |
| Repurchases of common stock | ($1.4B) | ($1.4B) | ($36.0M) |
| Net cash used in financing activities | ($1.4B) | ($1.4B) | ($30.0M) |
| Effect of foreign exchange on cash, cash equivalents, and restricted cash and cash equivalents | $4.0M | ($11.0M) | $3.0M |
| Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents | ($623.0M) | ($844.0M) | $694.0M |
| Cash, cash equivalents, and restricted cash and cash equivalents - beginning of period | $1.4B | $2.3B | $1.6B |
| Cash, cash equivalents, and restricted cash and cash equivalents - end of period | $827.0M | $1.4B | $2.3B |
| Cash paid for income taxes, net of tax refunds | $43.0M | $13.0M | $54.0M |
| Stock-based compensation capitalized as internal-use software | $42.0M | $35.0M | $56.0M |
| Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering | $0 | $0 | $2.8B |
| Reclassification of deferred offering costs to additional paid-in capital upon initial public offering | $0 | $0 | $9.0M |
| Accretion of Series A redeemable convertible preferred stock | $9.0M | $9.0M | $2.0M |
| Cash paid for amounts included in the measurement of operating lease liabilities | $9.0M | $16.0M | $16.0M |
| Lease liabilities arising from obtaining right-of-use assets | $0 | $1.0M | $6.0M |
| Remeasurement of operating lease right of use assets | $17.0M | — | $0 |
| Cash and cash equivalents | $637.0M | $1.3B | $2.1B |
| Restricted cash and cash equivalents, current | $172.0M | $152.0M | $137.0M |
| Restricted cash and cash equivalents, noncurrent | $18.0M | $19.0M | $19.0M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $256.0M | $144.0M | $366.0M | $222.0M |
| Depreciation and amortization expense | $62.0M | $30.0M | $65.0M | $40.0M |
| Stock-based compensation expense | $221.0M | $80.0M | $253.0M | $172.0M |
| Impairments of long-lived assets and other assets | $6.0M | $6.0M | $21.0M | — |
| Provision for bad debts | $6.0M | $3.0M | $12.0M | $9.0M |
| Amortization of operating lease right-of-use assets | $2.0M | $1.0M | $7.0M | $5.0M |
| Deferred income taxes | $67.0M | $38.0M | $66.0M | ($1.0M) |
| Other | $3.0M | $2.0M | ($4.0M) | $7.0M |
| Accounts receivable | $141.0M | $28.0M | ($35.0M) | ($31.0M) |
| Prepaid expenses and other assets | $21.0M | ($9.0M) | $46.0M | $46.0M |
| Accounts payable | ($8.0M) | ($22.0M) | ($3.0M) | ($12.0M) |
| Accrued and other current liabilities | ($34.0M) | ($51.0M) | ($17.0M) | $32.0M |
| Deferred revenue | $20.0M | $19.0M | $18.0M | $18.0M |
| Operating lease liabilities | ($1.0M) | ($1.0M) | ($7.0M) | ($6.0M) |
| Net cash provided by operating activities | $762.0M | $268.0M | $788.0M | $501.0M |
| Purchases of marketable securities | ($13.0M) | ($4.0M) | ($230.0M) | ($144.0M) |
| Maturities of marketable securities | $15.0M | $12.0M | $221.0M | $127.0M |
| Purchases of property and equipment, including capitalized internal-use software | ($29.0M) | ($16.0M) | ($49.0M) | ($34.0M) |
| Acquisitions of businesses, net of cash acquired | ($29.0M) | — | ($105.0M) | ($105.0M) |
| Other investing activities | $0 | — | ($1.0M) | ($1.0M) |
| Net cash used in investing activities | ($56.0M) | ($8.0M) | ($163.0M) | ($156.0M) |
| Taxes paid related to net share settlement of equity awards | ($8.0M) | ($4.0M) | ($21.0M) | ($14.0M) |
| Proceeds from exercise of stock options | $4.0M | $3.0M | $8.0M | $6.0M |
| Changes in advances from payment card issuer | $34.0M | $31.0M | $41.0M | $43.0M |
| Repurchases of common stock | ($683.0M) | ($359.0M) | ($272.0M) | ($210.0M) |
| Other financing activities | ($2.0M) | — | — | — |
| Net cash used in financing activities | ($655.0M) | ($328.0M) | ($245.0M) | ($175.0M) |
| Effect of foreign exchange on cash, cash equivalents, and restricted cash and cash equivalents | ($3.0M) | ($1.0M) | $4.0M | $5.0M |
| Net increase in cash, cash equivalents, and restricted cash and cash equivalents | $47.0M | ($68.0M) | $384.0M | $176.0M |
| Cash, cash equivalents, and restricted cash and cash equivalents - beginning of period | $827.0M | $827.0M | $1.4B | $1.4B |
| Cash, cash equivalents, and restricted cash and cash equivalents - end of period | $874.0M | $758.0M | $1.8B | $1.6B |
| Cash paid for (received from) income taxes, net | ($2.0M) | ($6.0M) | $41.0M | $42.0M |
| Stock-based compensation capitalized as internal-use software | $21.0M | $11.0M | $33.0M | $23.0M |
| Remeasurement of operating lease right-of-use assets | $0 | — | $17.0M | $17.0M |
| Cash and cash equivalents | $757.0M | $631.0M | $1.7B | $1.5B |
| Restricted cash and cash equivalents, current | $117.0M | $110.0M | $126.0M | $122.0M |
| Restricted cash and cash equivalents, noncurrent | $0 | $18.0M | $18.0M | $15.0M |
| Total cash, cash equivalents, and restricted cash and cash equivalents | $874.0M | $758.0M | $1.8B | $1.6B |
Maplebear Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.